Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbCellera Biologics Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ABCL
Nasdaq
2830
www.abcellera.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbCellera Biologics Inc.
Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued?
- Jul 29th, 2026 1:08 pm
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
- Jul 29th, 2026 5:00 am
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
- Jul 15th, 2026 6:45 am
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
- Jul 7th, 2026 2:05 pm
Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great Choice
- Jul 7th, 2026 10:00 am
AbCellera Appoints Dr. Lynn Seely to its Board of Directors
- Jul 6th, 2026 7:00 am
Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year?
- Jul 3rd, 2026 7:40 am
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside?
- Jul 1st, 2026 3:23 pm
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?
- Jun 28th, 2026 9:56 pm
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
- Jun 25th, 2026 6:45 am
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
- Jun 24th, 2026 7:13 am
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses Goal
- Jun 24th, 2026 2:09 am
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration
- Jun 23rd, 2026 1:39 pm
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies
- Jun 18th, 2026 8:29 am
Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year?
- Jun 17th, 2026 7:40 am
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed Rates Announcement
- Jun 17th, 2026 7:15 am
Jazz Pharmaceuticals and AbCellera Partner on Antibody Programs for Solid Tumors
- Jun 17th, 2026 6:50 am
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
- Jun 17th, 2026 5:00 am
Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Bet
- Jun 8th, 2026 7:55 am
A Look At AbCellera Biologics (ABCL) Valuation After ABCL635 Progress And Strong Q1 Results
- Jun 7th, 2026 12:11 am
Scroll